Amir Abbas Momtazi‐borojeni - Nanotechnology

Author Information

Amir Abbas Momtazi-Borojeni is affiliated with the Nanotechnology Research Center at the Bu-Ali Research Institute, Mashhad University of Medical Sciences in Mashhad, Iran. His research interests span across various domains, with a particular focus on nanotechnology applications in medical sciences.

Research Contributions

Amir Abbas Momtazi-Borojeni has made significant contributions to the field of medical sciences through his research on natural compounds and their effects on various diseases. His work includes studies on the neuroprotective effects of ferulic acid, the therapeutic potential of regulatory T cells in reducing cardiovascular complications in severe COVID-19 patients, and the anti-inflammatory properties of berberine. Additionally, his research has explored the immunomodulatory effects of curcumin in rheumatoid arthritis, the impact of PCSK9 immunization on glycemic indices in diabetic rats, and the association between genetic polymorphisms and type 2 diabetes susceptibility. His innovative approaches often incorporate nanotechnology, as evidenced by his work on PCSK9 inhibition-based therapies and nanoliposome-based immunizations to prevent hypercholesterolemia and atherosclerosis.

Aliases

Amir Abbas Momtazi-Borojeni has published under various aliases, including:
A. Momtazi-borojeni Amir Abbas Momtazi-borojeni Amir Abaas Momtazi-borojeni A A Momtazi-borojeni Amir A. Momtazi-borojeni Amir Abbas Momtazi–borojeni A. A. Momtazi-borojeni Amir A Momtazi-borojeni

Publication and Citation Metrics

Metric Value
h-index 30
Total Citations 2719
Total Papers 125

Publications:

DOI: 10.2174/0929867328666211027125245

Year: 2021

Partnered Content Networks

Relevant Topics